Three of the novel missense mutational cancer genes were mutated at >1% in their respective TCGA cancer types: ATP10D (9.4% in melanoma), SVIL (3.2% in ovarian carcinoma) and WDR36 (3.2% in bladder carcinoma, Supplementary Table S4). This evidence concerns the gene WDR36 and melanoma.